Seo-Yeon Ahn

403 total citations
26 papers, 215 citations indexed

About

Seo-Yeon Ahn is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Seo-Yeon Ahn has authored 26 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Genetics and 7 papers in Oncology. Recurrent topics in Seo-Yeon Ahn's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Seo-Yeon Ahn is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Seo-Yeon Ahn collaborates with scholars based in South Korea, Canada and United States. Seo-Yeon Ahn's co-authors include Sung‐Hoon Jung, Je‐Jung Lee, Hyeoung‐Joon Kim, Ga‐Young Song, Deok‐Hwan Yang, Jae‐Sook Ahn, Jae-Sook Ahn, Yeo‐Kyeoung Kim, Myung‐Geun Shin and Deok‐Hwan Yang and has published in prestigious journals such as Blood, Annals of Oncology and BMC Cancer.

In The Last Decade

Seo-Yeon Ahn

24 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seo-Yeon Ahn South Korea	7	123	73	65	51	47	26	215
Kaiyang Ding China	9	107 0.9×	113 1.5×	46 0.7×	100 2.0×	30 0.6×	51	241
Dennis Veldhuizen Netherlands	6	180 1.5×	87 1.2×	96 1.5×	81 1.6×	57 1.2×	7	316
Silja Mack Germany	4	158 1.3×	63 0.9×	49 0.8×	41 0.8×	89 1.9×	6	265
Cecilia Arana Yi United States	8	100 0.8×	55 0.8×	28 0.4×	80 1.6×	71 1.5×	21	210
Andrea Zangrando Italy	8	123 1.0×	95 1.3×	25 0.4×	147 2.9×	32 0.7×	9	303
Jean‐Valère Malfuson France	8	143 1.2×	50 0.7×	32 0.5×	142 2.8×	42 0.9×	15	250
Elisa Genuardi Italy	9	118 1.0×	110 1.5×	27 0.4×	114 2.2×	51 1.1×	25	231
Ryan J. Stubbins Canada	9	102 0.8×	80 1.1×	43 0.7×	94 1.8×	81 1.7×	26	286
Kota Fukumoto Japan	9	103 0.8×	73 1.0×	33 0.5×	81 1.6×	38 0.8×	20	195
Marzia Cavalli Italy	7	133 1.1×	86 1.2×	26 0.4×	44 0.9×	94 2.0×	16	286

Countries citing papers authored by Seo-Yeon Ahn

Since Specialization

Citations

This map shows the geographic impact of Seo-Yeon Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seo-Yeon Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seo-Yeon Ahn more than expected).

Fields of papers citing papers by Seo-Yeon Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seo-Yeon Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seo-Yeon Ahn. The network helps show where Seo-Yeon Ahn may publish in the future.

Co-authorship network of co-authors of Seo-Yeon Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Seo-Yeon Ahn. A scholar is included among the top collaborators of Seo-Yeon Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seo-Yeon Ahn. Seo-Yeon Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Ga‐Young, Seo-Yeon Ahn, Sung‐Hoon Jung, et al.. (2025). Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 281–288. 1 indexed citations

Kim, Suhyeon, Ji Ye Jung, Seo-Yeon Ahn, et al.. (2024). Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study. Frontiers in Oncology. 14. 1307315–1307315. 1 indexed citations

Song, Ga‐Young, Sung‐Hoon Jung, Seo-Yeon Ahn, et al.. (2024). Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell Lymphomas. The Korean Journal of Internal Medicine. 39(2). 327–337.

Kim, Mihee, Tae‐Hyung Kim, Seo-Yeon Ahn, et al.. (2023). The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine. The Korean Journal of Internal Medicine. 38(4). 534–545.

Vo, Manh-Cuong, Seo-Yeon Ahn, Mihee Kim, et al.. (2022). Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Translational Oncology. 20. 101413–101413. 6 indexed citations

Kim, Tae‐Hyung, Jae-Sook Ahn, Meong Hi Son, et al.. (2022). Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms. Leukemia Research. 118. 106858–106858. 1 indexed citations

Jung, Sung‐Hoon, Manh-Cuong Vo, Minh‐Trang Thi Phan, et al.. (2022). Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model. Cancer Immunology Immunotherapy. 72(5). 1233–1246. 9 indexed citations

Jung, Sung‐Hoon, Ho‐Young Yhim, Jae‐Cheol Jo, et al.. (2022). Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen. Blood Research. 57(1). 51–58. 3 indexed citations

Song, Ga‐Young, Sung‐Hoon Jung, Seo-Yeon Ahn, et al.. (2022). Prognostic Significance of 18f-FDG PET/CT in the Treatment of Primary Central Nervous System Lymphoma. Blood. 140(Supplement 1). 9571–9572. 1 indexed citations

10.

Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations

11.

Phan, Minh‐Trang Thi, Jin-Ho Kim, Jongmin Lee, et al.. (2021). Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Cancer Immunology Immunotherapy. 71(3). 613–625. 24 indexed citations

12.

Ahn, Seo-Yeon, Sung‐Hoon Jung, Manh-Cuong Vo, et al.. (2021). Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cellular and Molecular Immunology. 18(7). 1652–1661. 26 indexed citations

13.

Song, Ga‐Young, Sung‐Hoon Jung, Seo-Yeon Ahn, et al.. (2019). Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma. BMC Cancer. 19(1). 59–59. 9 indexed citations

14.

Ahn, Jae-Sook, Tae‐Hyung Kim, Yeo‐Kyeoung Kim, et al.. (2019). Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone. Experimental Hematology. 75. 26–30. 1 indexed citations

15.

Yang, Deok‐Hwan, Jae‐Sook Ahn, Seo-Yeon Ahn, et al.. (2019). Genomic Profiles and Subset Characterization of CD8+terminally Differentiated Effector Memory (TEMRA) Cells from Cancer Patients. Blood. 134(Supplement_1). 2329–2329. 2 indexed citations

16.

Lee, Je‐Jung, Manh-Cuong Vo, Seo-Yeon Ahn, et al.. (2019). A Combination Therapy with Dendritic Cells, Pomalidomide and Programmed Death-Ligand 1 Blockade Exerts a Potent Antitumor Immunity in a Murine Model of Multiple Myeloma. Blood. 134(Supplement_1). 1819–1819. 2 indexed citations

17.

Kim, Tae‐Hyung, Joon Ho Moon, Jae-Sook Ahn, et al.. (2018). Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse. Blood. 132(15). 1604–1613. 77 indexed citations

18.

Jung, Sung‐Hoon, Seo-Yeon Ahn, Je‐Jung Lee, et al.. (2018). Diagnostic Accuracy of Immunoglobulin Heavy Chain Rearrangement, FDG-PET/CT and Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Diffuse Large B Cell Lymphoma. Blood. 132(Supplement 1). 4236–4236. 1 indexed citations

19.

Ahn, Jae‐Sook, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, et al.. (2017). Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML. Blood. 130. 5075–5075. 1 indexed citations

20.

Jung, Sung‐Hoon, Seo-Yeon Ahn, Myung‐Geun Shin, et al.. (2017). STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma. Blood Research. 52(4). 293–293. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact